tiprankstipranks
Trending News
More News >

Robert Peter Kadlec Insider Profile

4 Followers
Robert Peter Kadlec, Director at MiNK Therapeutics, holds 2.76K shares in MiNK Therapeutics (Ticker: INKT).
tipranks
Robert Peter Kadlec

Robert Peter Kadlec
MiNK Therapeutics (INKT)
Director

Not Ranked
Robert Peter Kadlec has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$23K
100.00%
A breakdown of Robert Peter Kadlec's holdings

Insider Roles

MiNK Therapeutics
(INKT)
Director
Roles that Robert Peter Kadlec holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Robert Peter Kadlec

Robert Peter Kadlec's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MiNK Therapeutics
Mar 05, 2025
Director
Uninformative Buy
13.50K
$22.66K
Robert Peter Kadlec has not reported any informative transactions for INKT, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 09, 2024
Uninformative Buy
$8.97K
-
$0.73
Mar 05, 2025
Uninformative Buy
$13.50K
-
$8.79
List of latest transactions for each holding click on a transaction to see Robert Peter Kadlec's performance on stock

Robert Peter Kadlec insider profile FAQ

What is the percentage of profitable transactions made by Robert Peter Kadlec?
The percentage of profitable transactions made by Robert Peter Kadlec is ―.
    What is the average return per transaction made by Robert Peter Kadlec?
    The average return per transaction made by Robert Peter Kadlec is ―.
      What stocks does Robert Peter Kadlec hold?
      Robert Peter Kadlec holds: INKT stocks.
        What was Robert Peter Kadlec’s latest transaction?
        Robert Peter Kadlec latest transaction was an Uninformative Buy of $13.50K.
          What was Robert Peter Kadlec's most profitable transaction?
          Robert Peter Kadlec’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Robert Peter Kadlec's role in MiNK Therapeutics?
            Robert Peter Kadlec's role in MiNK Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.